Two Honors for HSCI's Scadden and Daley

David T. Scadden, MD
Co-Scientific Director of HSCI

Following a highly selective process that considers experts who have made major contributions to the advancement of the medical sciences, health care, and public health, David T. Scadden, MD of Massachusetts General Hospital, has been elected to the Institute of Medicine (IOM) of the National Academies. The IOM is both a research and an honorary membership organization that works outside the framework of the government to provide advice on national issues relating to biomedical science, medicine and health. Scadden is among 65 new members elected this year.

Election to the IOM is considered one of the highest honors in the fields of medicine and health. Collectively, members of the IOM serve as a national resource for unbiased, evidence-based and authoritative information and advice concerning health and science policy to policymakers, professionals, leaders and the general public.

George Daley, MD, PhD
HSCI Principal Faculty
HSCI Executive Committee Member

George Daley, MD, PhD of Children's Hospital Boston, has been appointed by the Howard Hughes Medical Institute to be an HHMI Investigator. The 15 researchers to receive this honor were selected from a poll of 242 candidates, and will receive $10 million during their first five-year term.

HHMI support will also enable Daley to work toward his goal of reprogramming a patient's own cells to revert to an embryonic state, from which different types of healthy replacement tissues can be made, and to expand his research on human embryonic stem cell lines.

"It is tremendously exciting that HHMI funding will give me greater flexibility to do research on newer embryonic stem cell lines and take it in a direction that won't be as limited," says Daley, who is also current president of the International Society for Stem Cell Research.

Click here, to view all spotlights.